Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patient-Reported Outcomes Valued in RA Management

Publish date:: October 7, 2019

Rheumatologists highly value patient-reported rheumatoid arthritis (RA) symptoms and physical function to inform their treatment decisions, a new study found. Rheumatologists were recruited nationally to participate in moderated structured group teleconference discussions. Participants in each group generated lists of the elements from patient history ad signs that they use to make treatment recommendations for RA. Among the findings:

25 rheumatologists participated in 4 groups and 150 available raking votes across all groups.
The statement generated across the 4 groups were categorized into 13 topics, 10 of which received ranking votes.
Symptoms received the highest ranking (46%), followed by physical function (16%), and physical findings (13%).

Citation:

Jagpal A, et al. Which patient reported outcome domains are important to the rheumatologist while evaluating patients with rheumatoid arthritis? [Published online ahead of print September 5, 2019]. BMC Rheumatol. doi: 10.1186/s41927-019-0087-2.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

Weight loss may be paramount lifestyle change in preventing gout,

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Must Reads in Rheumatoid Arthritis

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Tocilizumab, methotrexate combo equals tocilizumab alone for preventing progression,

Biomarker-based prognostic score identifies cardiovascular risk in RA,

Early life exposure to famine raises risk of RA in adulthood,